Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06801080 · ClinicalTrials.gov registry record · NA

Well Baby, Well Family Study

A NA study of Social Determinants of Health, sponsored by Naval Health Research Center.

Active
Registry status
NA
Development phase
1,181
Enrollment target
2
Study locations

NCT06801080: Active NA study of Social Determinants of Health, sponsored by Naval Health Research Center.

NCT06801080 is a NA study of Social Determinants of Health that is active but no longer recruiting, run by Naval Health Research Center. The registered enrollment target is 1,181 participants, below the 4,934-participant average among 11 other Social Determinants of Health trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06801080, a NA study of Social Determinants of Health, is active but no longer recruiting, sponsored by Naval Health Research Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,181 participants
Enrollment target
2
Study locations

Study Summary

BACKGROUND: The Defense Health Agency (DHA) and the Office of Military Community and Family Policy (MC\&FP) requested assistance in evaluating the effectiveness of a military pilot implementation of a civilian program designed to assist families with infants called HealthySteps (HS; HealthySteps National Office, 2018). HS is a unique pediatric primary care-based program that helps families identify and manage parenting challenges. The program interweaves the medical support of the pediatrician's office with the resources and services of a HS Specialist trained to help parents understand their infants' needs (e.g., feeding, behavior, sleep) and their role as caregivers. HS Specialists provide enhanced educational support and facilitate targeted referrals to other relevant DoD and civilian support resources. OBJECTIVE: The HS program has not been widely implemented or evaluated previously in a military context. However, a small 2-site pilot was initiated in 2017 by MC\&FP to assess the feasibility of offering the HS program in military treatment facilities (MTF). The Defense Health Agency (DHA) further determined that this pilot program could be expanded to fulfill a 2019 National Defense Authorization Act (NDAA) requirement for the implementation and evaluation of a pilot program to reduce risk factors for child abuse and neglect within the U.S. military community. APPROACH: This outcome evaluation study entailed a review of medical records for families enrolled in the HS pilot as well as the collection of prospective survey data. Survey data collected from primary caregivers enrolled in HS at seven implementation locations throughout the U.S. is being compared with survey data collected from caregivers of newborns seeking care at control locations offering pediatric treatment as usual. VALUE: The HS program is expected to improve parental engagement in well-baby care, increase targeted screenings and referrals, improve parental efficacy and knowledge, as well as

Primary Outcome

We examined appointment file data in medical records for participating families to document well-child care (WCC) adherence. This was operationalized as the extent to which beneficiary caregivers brought their infants into the clinic for recommended well-child visits (Current Procedural Terminology codes 99381 and 99391). On-time well child visits were flagged using a classification strategy modeled after Goyal (2020) and based on a slightly modified version of the Bright Futures recommended per

Interventions

  • OTHER Treatment as Usual (TAU)
  • OTHER HealthySteps (https://www.zerotothree.org/our-work/healthysteps/)

Study Locations (2)

California

  • Naval Health Research Center - San Diego

Maryland

  • Abt Global - Rockville

Trial Details

FieldValue
Enrollment Target 1,181 participants
Start Date 2022-01-05
Est. Completion 2025-05-31
Phase NA
Naval Health Research Center

3 total trials

What the registry record for NCT06801080 still lists

NCT06801080 is an interventional study that assigns participants to a tested intervention. Its 1,181 participants enrollment target places it among the larger protocols in the corpus, below the 4,934-participant average among 11 other Social Determinants of Health trials with a reported enrollment target (76% lower).

The record links to 1 condition, with Social Determinants of Health appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.

NCT06801080 reports a single indexed study location in California, Maryland.

Frequently Asked Questions

What is clinical trial NCT06801080 about?

NCT06801080 is a clinical study titled "Well Baby, Well Family Study". BACKGROUND: The Defense Health Agency (DHA) and the Office of Military Community and Family Policy (MC\&FP) requested assistance in evaluating the effectiveness of a military pilot implementation of a civilian program designed to assist families with infants called HealthySteps (HS; HealthySteps Nat...

What is the current status of trial NCT06801080?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,181 participants. The study started on 2022-01-05. Estimated completion is 2025-05-31.

What conditions does trial NCT06801080 study?

This clinical trial studies the following conditions: Social Determinants of Health.

What interventions are being tested in trial NCT06801080?

The interventions under investigation include: Treatment as Usual (TAU) (OTHER), HealthySteps (https://www.zerotothree.org/our-work/healthysteps/) (OTHER).

Who is sponsoring clinical trial NCT06801080?

This trial is sponsored by Naval Health Research Center, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06801080 being conducted?

This trial has 2 study locations across California, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Social Determinants of Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06801080's enrollment target sits among peer trials

1,181 4th of 11 higher than 8 of 11 other Social Determinants of Health trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Social Determinants of Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07286058 · 1,182 participants · Phase 3

    Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

  • NCT05688436 · 1,178 participants

    A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies

  • NCT06931275 · 1,178 participants · NA

    Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes

  • NCT04293562 · 1,186 participants · Phase 3

    A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06801080, the US trial registry maintained by the National Library of Medicine. NCT06801080 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.